Hisamitsu Pharmaceutical Co.,Inc.
https://global.hisamitsu/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Hisamitsu Pharmaceutical Co.,Inc.
Deal Watch: AZ, Alchemab To Study Immune Response For Novel Cancer Targets
Also, deals involving AbCellera/Angios, AstraZeneca/Alchemab, Kowa/Esteve, OSE/Veloxis, Tris/Park, Core One/Akome and Vertex/Obsidian.
Salonpas Spreads Into OTC Diclofenac Arthritis Gel
Hisamitsu America launches Salonpas Arthritis Pain Relief Gel with same active ingredient, diclofenac sodium 1% gel, that became available OTC for the first time in the US in 2020 with GSK’s Voltaren Arthritis Pain formulation.
In GSK Challenge Of Salonpas Claims, NAD Embarks On Review Of Unchartered Argument
Hisamitsu America’s severity of pain claims for Salonpas challenged by GSK are more nuanced than what label indications support, but touting its regulatory approval doesn’t convey a message that other products aren’t subject to as rigorous pre-market evaluations.
UK Marketing: Sanofi Launches Buscomint, New Releases From Salonpas and Nailner
The latest OTC launches in the UK, including Buscomint from Sanofi, Salonpas Gel-Patch from Hisamitsu and Nailner Active Cover from Karo.
Company Information
- Industry
- Medical Devices
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
- OTC, Consumer
-
Drug Delivery
- Transdermal
- Other Names / Subsidiaries
-
- CRCC Media Co.,Ltd. (Fukuoka)
- Saga City-Vision Co.,Ltd. (Saga)
- Taiyo Co.,Ltd (Saga)
- Kyudo Co.,Ltd (Saga)
- Hisamitsu Agency Co.,Ltd. (Fukuoka)
- Hisamitsu U.S., Inc.
- Hisamitsu America, Inc.
- Noven Pharmaceuticals, Inc.
- Hisamitsu Farmaceutica do Brasil Ltda.
- Hisamitsu UK Ltd.
- Hisamitsu Italia S.r.l.
- Hisamitsu Vietnam Pharmaceutical Co.,Ltd.
- Hisamitsu Pharmaceutical(China)Co.,Ltd.
- Hisamitsu Pharmaceutical Technology Consulting(Beijing) Co.,Ltd.
- Hisamitsu Pharmaceutical (Hong Kong)Co.,Ltd.
- PT. Hisamitsu Pharma Indonesia